Relapse after localized rhabdomyosarcoma: Evaluation of the efficacy of second-line chemotherapy.
about
Pediatric Gynecologic Cancers.Sertoli-Leydig Cell Tumor with Concurrent Rhabdomyosarcoma: Three Case Reports and a Review of the LiteratureA patient-derived orthotopic xenograft (PDOX) mouse model of a cisplatinum-resistant osteosarcoma lung metastasis that was sensitive to temozolomide and trabectedin: implications for precision oncology.VIncristine, irinotecan, and temozolomide in children and adolescents with relapsed rhabdomyosarcoma.Consensus and controversies regarding the treatment of rhabdomyosarcoma.Treatment Outcomes in Children and Adolescents with Relapsed or Progressed Solid Tumors: a 20-year, Single-Center Study
P2860
Relapse after localized rhabdomyosarcoma: Evaluation of the efficacy of second-line chemotherapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Relapse after localized rhabdo ...... y of second-line chemotherapy.
@en
type
label
Relapse after localized rhabdo ...... y of second-line chemotherapy.
@en
prefLabel
Relapse after localized rhabdo ...... y of second-line chemotherapy.
@en
P2093
P2860
P356
P1476
Relapse after localized rhabdo ...... y of second-line chemotherapy.
@en
P2093
Daniel Orbach
Sarah Winter
Sylvie Fasola
Véronique Mosseri
P2860
P304
P356
10.1002/PBC.25622
P577
2015-07-06T00:00:00Z